Compare STVN & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STVN | CHH |
|---|---|---|
| Founded | 1949 | 1939 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Hotels/Resorts |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.7B |
| IPO Year | 2021 | 1997 |
| Metric | STVN | CHH |
|---|---|---|
| Price | $16.99 | $104.13 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 15 |
| Target Price | $23.75 | ★ $116.79 |
| AVG Volume (30 Days) | 567.7K | ★ 810.0K |
| Earning Date | 03-05-2026 | 02-19-2026 |
| Dividend Yield | 0.37% | ★ 1.09% |
| EPS Growth | 19.61 | ★ 56.73 |
| EPS | 0.60 | ★ 8.11 |
| Revenue | ★ $1,373,219,524.00 | $819,632,000.00 |
| Revenue This Year | $8.42 | $101.85 |
| Revenue Next Year | $9.61 | $1.88 |
| P/E Ratio | $28.91 | ★ $13.04 |
| Revenue Growth | ★ 6.97 | N/A |
| 52 Week Low | $16.30 | $84.04 |
| 52 Week High | $28.00 | $157.86 |
| Indicator | STVN | CHH |
|---|---|---|
| Relative Strength Index (RSI) | 28.57 | 53.61 |
| Support Level | $16.30 | $102.87 |
| Resistance Level | $19.94 | $106.77 |
| Average True Range (ATR) | 1.03 | 3.80 |
| MACD | -0.36 | -0.51 |
| Stochastic Oscillator | 11.75 | 42.96 |
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
At year-end 2024, Choice Hotels operated 654,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (26% of the company's total domestic rooms), while Ascend and Cambria (10%) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2024.